StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.11+0.12 (+0.75%)

Close on Nov 17, 2026Market cap $2.98BP/E –Yield –

Earnings

Legend Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 11, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$387.50M
+51.9% on a year earlier
Adjusted EPS, Q2 FY2026
$0.16
$0.03 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Legend Biotech's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 11, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 11, 2026before the open$387.50M+51.9%$0.09$0.16Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open$305.10M+56.4%-$0.15-$0.03Release
Q4 FY2025ended Dec 31, 2025Mar 10, 2026before the open$306.30M+64.2%-$0.08$0.01Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$272.33M+70.0%-$0.11-$0.05Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025before the open$255.06M–-$0.34$0.03Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open$195.05M+107.5%-$0.27-$0.07Release
Q4 FY2024ended Dec 31, 2024Mar 11, 2025before the open$186.52M–$0.07-$0.15Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$160.21M–-$0.34–Release
Q2 FY2024ended Jun 30, 2024Jul 26, 2024before the open––––Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open$93.99M–-$0.16–Release
Q4 FY2023ended Dec 31, 2023Mar 11, 2024before the open––––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Legend Biotech has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Legend Biotech puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Legend Biotech filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?